Functional characterization of IL-13 receptor α2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression

被引:0
|
作者
Muriel D David
Jacques Bertoglio
Josiane Pierre
机构
[1] INSERM U461,
[2] Faculte de Pharmacie,undefined
[3] 5,undefined
[4] rue JB Clement,undefined
来源
Oncogene | 2003年 / 22卷
关键词
cytokine receptors; gene regulation; transcription factors; cytokines; keratinocytes;
D O I
暂无
中图分类号
学科分类号
摘要
Interleukin (IL)-4 and IL-13 are two structurally and functionally related cytokines that have overlapping but also distinct biological activities. One of the components of the IL-13 receptor, the α2 chain (IL-13Rα2), has been reported to downregulate the cell responsiveness to IL-13, without affecting IL-4 signaling. Here, we report that TNFα synergizes with either IL-4 or IL-13 in inducing the IL-13Rα2 chain at both the mRNA and protein levels in the HaCaT human keratinocyte cell line. Further studies by 5′RACE identified as yet undescribed exonic sequences of the IL-13Rα2 5′UTR, provided evidence for the expression of alternatively spliced IL-13Rα2 transcripts and defined the transcription start of the IL-13Rα2 gene. A 1.5 kb region upstream of the first exon of the IL-13Rα2 gene displayed basal promoter activity when inserted in a reporter plasmid and transiently transfected in HaCaT cells. This promoter activity was further increased in response to IL-4 and IL-13. Furthermore, by electrophoretic mobility shift assay and site-directed mutagenesis, we showed that the IL-4/IL-13-induced promoter activity depended upon a positively acting STAT6 response element. Finally, TNFα was shown to potentiate IL-4/IL-13-induced IL-13Rα2 promoter activity when the same reporter construct was studied in stably but not in transiently transfected cells. These results suggest that the synergistic effect of TNFα on IL-4/IL-13-induced IL-13Rα2 expression is dependent upon chromatin re-modeling events.
引用
收藏
页码:3386 / 3394
页数:8
相关论文
共 50 条
  • [21] Requirements for interleukin-4-induced gene expression and functional characterization of Stat6
    Mikita, T
    Campbell, D
    Wu, PG
    Williamson, K
    Schindler, U
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (10) : 5811 - 5820
  • [22] IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6
    Ohmori, Y
    Smith, MF
    Hamilton, TA
    JOURNAL OF IMMUNOLOGY, 1996, 157 (05): : 2058 - 2065
  • [23] Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma
    Antczak, Adam
    Domanska-Senderowska, Daria
    Gorski, Pawel
    Pastuszak-Lewandoska, Dorota
    Nielepkowicz-Gozdzinska, Agnieszka
    Szewczyk, Karolina
    Kurmanowska, Zofia
    Kiszalkiewicz, Justyna
    Brzezianska- Lasota, Ewa
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2016, 29 (02) : 195 - 204
  • [24] IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
    Wei, LH
    Jacobs, AT
    Morris, SM
    Ignarro, LJ
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (01): : C248 - C256
  • [25] Interferon Gamma Inhibits Th2 Induced Mucus Metaplasia in vivo Through Effects on Epithelial IL-4 and IL-13 Receptor Expression, and Inhibition of Stat6 Phosphorylation
    Provost, K.
    Niu, N.
    Homer, R. J.
    Cohn, L. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [26] Correction: Corrigendum: IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics
    Steven O’Reilly
    Marzena Ciechomska
    Nicola Fullard
    Stefan Przyborski
    Jacob M. van Laar
    Scientific Reports, 6
  • [27] IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics (vol 6, 25066, 2016)
    O'Reilly, Steven
    Ciechomska, Marzena
    Fullard, Nicola
    Przyborski, Stefan
    van Laar, Jacob M.
    SCIENTIFIC REPORTS, 2016, 6
  • [28] Eblasakimab, a novel IL-13 receptor alpha 1 monoclonal antibody, blocks STAT6 phosphorylation with low dose in human volunteers
    Cevikbas, Ferda
    Ward, Alison
    Firth, Carl
    Veverka, Karen
    CLINICAL IMMUNOLOGY, 2023, 253
  • [29] Toll-like receptor 4 (TLR4) expression after IL-13 gene transfer is Stat6-dependent.
    Ke, BH
    Shen, XD
    Gao, F
    Farmer, DG
    Busuttil, RW
    Kupiec-Weglinski, JW
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 538 - 538
  • [30] Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes
    Shibuya, H.
    Yoneyama, M.
    Taniguchi, T.
    INTERNATIONAL IMMUNOLOGY, 1989, 1 (01) : 43 - 49